Effects of Brain Stimulation on Higher-Order Cognition
Primary Purpose
Schizophrenia
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Transcranial Direct Current Stimulation
Sponsored by
About this trial
This is an interventional basic science trial for Schizophrenia focused on measuring schizophrenia, EEG, tDCS, dorsolateral prefrontal cortex, cognitive control, language, transcranial direct current stimulation
Eligibility Criteria
Inclusion Criteria:
- Participants must be able to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks.
- All subjects must have the ability to give valid informed consent.
Inclusion Criteria for Patients with Schizophrenia Only:
- Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
- No medication changes in the prior month
- No medication changes anticipated in the upcoming month
- Stable outpatient or partial hospital status
- Normal IQ (>70; IQ will be measured by administering the Wechsler Abbreviated Scale of Intelligence (WASI) test)
- Must not be currently taking the antipsychotic clozapine
Exclusion Criteria:
- Pacemakers
- Implanted electrical (brain and spinal) stimulators
- Implanted defibrillator
- Metallic implants
- Skin damage or skin conditions such as eczema at the sites where electrodes will be placed
- Hair styles hindering the placement of electrodes
- Cranial pathologies
- Head trauma
- Epilepsy
- Mental retardation
- Any known history of neurological disorders (including epilepsy, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, cerebral palsy, any DSM-5 axis I psychiatric disorder (for healthy control subjects), autism)
- Uncorrected vision problems that would hinder cognitive testing (this also pertains to subjects with color blindness in tasks where discriminating colored objects/items is necessary for successful performance)
- Pregnancy
- Substance dependence in the past six months
- Substance abuse in the past month
Sites / Locations
- Imaging Research CenterRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Experimental
Active Comparator
Sham Comparator
Arm Label
DLPFC Stimulation
Occipital Stimulation
Sham Stimulation
Arm Description
Intervention. 20 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex.
Intervention. 20 minutes of 2 mA direct current stimulation over the occipital cortex.
Placebo Comparator. 0.5-1 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex followed by 19-19.5 minutes of sham stimulation
Outcomes
Primary Outcome Measures
EEG Correlates of Language and Cognitive Control
Electrophysiological data recorded during completion of cognitive control and language comprehension tasks. We will measure oscillatory activity in the theta, alpha, beta and gamma frequency bands.
Behavioral Response (Cognitive Control Task)
We will assess performance on the Dot Pattern Expectancy (DPX) task (error rates and d-prime scores).
Behavioral Response (Language Task)
We will assess performance on a novel Language Comprehension task (accuracy and semantic relatedness judgement scores).
Secondary Outcome Measures
Full Information
NCT ID
NCT03814967
First Posted
January 15, 2019
Last Updated
September 14, 2023
Sponsor
University of California, Davis
1. Study Identification
Unique Protocol Identification Number
NCT03814967
Brief Title
Effects of Brain Stimulation on Higher-Order Cognition
Official Title
Transcranial Direct Current Stimulation (tDCS) Studies of Behavioral and Electrophysiological (EEG) Correlates of Higher-Order Cognition
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 22, 2019 (Actual)
Primary Completion Date
January 31, 2024 (Anticipated)
Study Completion Date
January 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, Davis
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to better understand the neural correlates of higher-order cognition, both in the healthy brain and in schizophrenia, and to determine how these mechanisms are modulated by transcranial direct current stimulation (tDCS) at frontal and occipital scalp sites. Testing the effects of tDCS at these scalp sites on cognitive task performance will help us understand the roles of the brain regions corresponding to these sites during higher-order cognitive processing (language comprehension, cognitive control, and related attention and memory processes). Behavioral and electrophysiological (EEG) measures will be used to assess cognitive performance. The investigator's overarching hypothesis is that stimulating prefrontal circuits with tDCS can improve cognitive control performance, and ultimately performance on a range of cognitive tasks, as compared to stimulating a different cortical region (occipital cortex) or using sham stimulation. This study is solely intended as basic research in order to understand brain function in healthy individuals and individuals with schizophrenia. This study is not intended to diagnose, cure or treat schizophrenia or any other disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Schizophrenia
Keywords
schizophrenia, EEG, tDCS, dorsolateral prefrontal cortex, cognitive control, language, transcranial direct current stimulation
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
DLPFC Stimulation
Arm Type
Experimental
Arm Description
Intervention. 20 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex.
Arm Title
Occipital Stimulation
Arm Type
Active Comparator
Arm Description
Intervention. 20 minutes of 2 mA direct current stimulation over the occipital cortex.
Arm Title
Sham Stimulation
Arm Type
Sham Comparator
Arm Description
Placebo Comparator. 0.5-1 minutes of 2 mA direct current stimulation over the dorsolateral prefrontal cortex followed by 19-19.5 minutes of sham stimulation
Intervention Type
Device
Intervention Name(s)
Transcranial Direct Current Stimulation
Intervention Description
In tDCS, saline-soaked electrodes are temporary affixed to the scalp and connected to a battery-powered current generator. A weak (2 mA) constant current is then briefly applied (~20 minutes) to stimulate the targeted brain area (e.g. the DLPFC). To control for placebo effects, the study will utilize a sham stimulation protocol that consists of very brief constant stimulation (~1 minute). Subjects usually cannot discern the difference between the sham and experimental stimulation protocols due to habituation.
Primary Outcome Measure Information:
Title
EEG Correlates of Language and Cognitive Control
Description
Electrophysiological data recorded during completion of cognitive control and language comprehension tasks. We will measure oscillatory activity in the theta, alpha, beta and gamma frequency bands.
Time Frame
Assessment will begin immediately following stimulation and last for about 1.5 hours.
Title
Behavioral Response (Cognitive Control Task)
Description
We will assess performance on the Dot Pattern Expectancy (DPX) task (error rates and d-prime scores).
Time Frame
Assessment will begin immediately following stimulation and last for about 1.5 hours.
Title
Behavioral Response (Language Task)
Description
We will assess performance on a novel Language Comprehension task (accuracy and semantic relatedness judgement scores).
Time Frame
Assessment will begin immediately following stimulation and last for about 1.5 hours.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Participants must be able to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks.
All subjects must have the ability to give valid informed consent.
Inclusion Criteria for Patients with Schizophrenia Only:
Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
No medication changes in the prior month
No medication changes anticipated in the upcoming month
Stable outpatient or partial hospital status
Normal IQ (>70; IQ will be measured by administering the Wechsler Abbreviated Scale of Intelligence (WASI) test)
Exclusion Criteria:
Pacemakers
Implanted electrical (brain and spinal) stimulators
Implanted defibrillator
Metallic implants
Skin damage or skin conditions such as eczema at the sites where electrodes will be placed
Hair styles hindering the placement of electrodes
Cranial pathologies
Head trauma
Epilepsy
Mental retardation
Any known history of neurological disorders (including epilepsy, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, cerebral palsy, any DSM-5 axis I psychiatric disorder (for healthy control subjects), autism)
Uncorrected vision problems that would hinder cognitive testing (this also pertains to subjects with color blindness in tasks where discriminating colored objects/items is necessary for successful performance)
Pregnancy
Substance dependence in the past six months
Substance abuse in the past month
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Megan A Boudewyn, Ph.D.
Phone
831-459-5084
Email
mboudewyn@ucsc.edu
Facility Information:
Facility Name
Imaging Research Center
City
Sacramento
State/Province
California
ZIP/Postal Code
95817
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Minhtrang Chu, BS
Phone
916-734-1482
Email
mihchu@ucdavis.edu
First Name & Middle Initial & Last Name & Degree
Cameron Carter, M.D.
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
Select data from this study may be submitted to the National Institute of Mental Health Data Archive (NDA). NDA is a data repository run by the National Institute of Mental Health (NIMH) that allows researchers studying mental illness to collect and share de-identified information with each other. The data repository is accessible only to qualified investigators. All subject data will be de-identified (subject names will not be used) and each subject will have a separate identifier called a Global Unique Identifier (GUID) to remove any possibility that "the identities of the subjects cannot be readily ascertained or otherwise associated with the data by the repository staff or secondary data users." (45 CFR, 46.102).
Links:
URL
https://studypages.com/s/a-study-of-the-effects-of-brain-stimulation-on-higher-order-cognition-761403/
Description
Learn more or sign up for the study here!
Learn more about this trial
Effects of Brain Stimulation on Higher-Order Cognition
We'll reach out to this number within 24 hrs